Table 9.
Cardioplegia solutions and delivery systems by region.
| NA (%) | SA (%) | Asia (%) | OA (%) | EU (%) | Total (%) | |
|---|---|---|---|---|---|---|
| Cardioplegia Solution | (n = 89) | (n = 8) | (n = 16) | (n = 4) | (n = 36) | (n = 153) |
| Hyperpolarizing (Custodiol® HTK) | 8 | 50 | 6 | 0 | 58 | 22 |
| Depolarizing (High Potassium) | 22 | 50 | 69 | 100 | 56 | 39 |
| Modified Depolarizing (del Nido) | 74 | 25 | 69 | 0 | 11 | 54 |
| Cardioplegia Delivery System | ||||||
| Recirculating | 30 | 25 | 31 | 25 | 40 | 32 |
| Single Pass | 70 | 50 | 69 | 75 | 31 | 60 |
| Syringe | 0 | 50 | 0 | 0 | 9 | 3 |
| Do not use | 0 | 0 | 0 | 0 | 6 | 1 |
| Other | 0 | 13 | 0 | 0 | 14 | 4 |
Recirculating, prepared in a batch and recirculated through a reservoir system. Singe pass, solution and blood passes one time through the cardioplegia heat exchanger. Syringe, drawing up in a syringe and injected directly.